Memory loss caused by Alzheimer's can be restored: Study

Image
IANS New York
Last Updated : Jan 25 2019 | 7:11 PM IST

Researchers have developed a novel approach that may one day make it possible to reverse memory loss, caused by Alzheimer's disease.

The team, led by University at Buffalo scientists, found that by focusing on gene changes caused by influences other than DNA sequences -- called epigenetics -- it was possible to reverse memory decline in an animal model of Alzheimer's.

"We have not only identified the epigenetic factors that contribute to the memory loss, but we also found ways to temporarily reverse them in an animal model of Alzheimer's," said Zhen Yan, Professor at University at Buffalo in the US.

The research, published in the journal Brain, was conducted on mouse models carrying gene mutations for familial Alzheimer's -- where more than one member of a family has the disease -- and on post-mortem brain tissues from Alzheimer's patients.

Alzheimer's is caused from both genetic and environmental risk factors, such as ageing, which combine to result in epigenetic changes, leading to gene expression changes, but little is known about how that occurs.

The epigenetic changes in Alzheimer's happen primarily in the later stages, when patients are unable to retain recently learned information and exhibit the most dramatic cognitive decline, Yan said.

A key reason for the cognitive decline is the loss of glutamate receptors, which are critical to learning and short-term memory.

The researchers found that the loss of glutamate receptors is the result of an epigenetic process known as repressive histone modification, which is elevated in Alzheimer's.

"Our study not only reveals the correlation between epigenetic changes and Alzheimer's, we also found we can correct the cognitive dysfunction by targeting the epigenetic enzymes to restore glutamate receptors," Yan said.

The Alzheimer's animals were injected three times with compounds designed to inhibit the enzyme that controls repressive histone modification.

In animals who received the enzyme inhibitor the cognitive function restored and was confirmed through evaluations of recognition memory, spatial memory and working memory.

The improvements lasted for one week. Future studies will focus on developing compounds that penetrate the brain more effectively and are thus longer-lasting, the researchers said.

--IANS

rt/rs/nir

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 25 2019 | 6:54 PM IST

Next Story